Orion Health has been awarded the 2016 European Frost & Sullivan Award for Product Leadership, recognising the company's pioneering approach to population health management (PHM), supporting its vision for delivering precision medicine. Global research and consulting organisation Frost & Sullivan conducted a recent analysis of the PHM solutions market and praised Orion Health for the "unmatched reliability and quality" of its technology, compared to other electronic health record (EHR) vendors.

Merck Sharp & Dohme Ltd (MSD), a global healthcare company, and Wayra UK, part of Telefonica Open Future, open a second call for the digital start-up community to create radical solutions that reimagine how healthcare can be delivered to help improve delivery and patient outcomes.

Sandoz, the Novartis generic and biosimilar pharmaceutical division, announces the launch of Sandoz HACk - Healthcare Access Challenge - a global competition to generate innovative ideas and solutions to help tackle some of the world's most pressing healthcare access problems. The competition is open for entries until November 30, 2016.

Accenture has announced the creation of the Accenture HealthTech Innovation Challenge which brings together leading-edge startups with prominent life sciences and health companies to tackle some of the world's greatest health challenges including access, affordability and transparency.

Royal Philips (NYSE: PHG; AEX: PHIA) and Qualcomm Incorporated (NASDAQ: QCOM) through its subsidiary, Qualcomm Life, Inc., have announced a strategic technology collaboration to advance connected health across the health continuum - from healthy living and prevention to chronic care management and home care.

The U.S. Food and Drug Administration has announced the 2016 Naloxone App Competition, a public contest focused on developing innovative technologies to combat the rising epidemic of opioid overdose. The FDA, with support from the National Institute on Drug Abuse (NIDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA), is inviting computer programmers, public health advocates, clinical researchers, entrepreneurs and innovators from all disciplines to

Royal Philips (NYSE: PHG, AEX: PHIA) has unveiled its latest innovation in interventional oncology at the 2016 Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE 2016), which was held in Barcelona (Spain) from September 10 until 14. Philips' next generation interventional oncology solution OncoSuite will enable physicians to provide analysis and minimally invasive, targeted treatment of tumor lesions reducing the impact to healthy tissue.